GEN Exclusives

More »

GEN News Highlights

Back to Item »

Pfizer Ends CytomX "Probody" Cancer Collaboration

Pfizer has terminated its five-year-old partnership with CytomX Therapeutics to use its Probody™ drug-development platform to develop and commercialize ...

Forward this item to a colleague:


(Separate multiple addresses by commas)